AQR Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Sell |
10,038
-588
| -6% | -$11K | ﹤0.01% | 3063 |
|
|
2025
Q1 | $191K | Buy |
+10,626
| New | +$191K | ﹤0.01% | 2901 |
|
|
2022
Q2 | – | Sell |
-3,111
| Closed | -$93K | – | 2280 |
|
|
2022
Q1 | $93K | Sell |
3,111
-1,488
| -32% | -$44.5K | ﹤0.01% | 2143 |
|
|
2021
Q4 | $122K | Hold |
4,599
| – | – | ﹤0.01% | 2133 |
|
|
2021
Q3 | $167K | Hold |
4,599
| – | – | ﹤0.01% | 2164 |
|
|
2021
Q2 | $200K | Hold |
4,599
| – | – | ﹤0.01% | 2143 |
|
|
2021
Q1 | $157K | Sell |
4,599
-345
| -7% | -$11.8K | ﹤0.01% | 2136 |
|
|
2020
Q4 | $173K | Buy |
4,944
+2,520
| +104% | +$88.2K | ﹤0.01% | 2107 |
|
|
2020
Q3 | $58K | Buy |
+2,424
| New | +$58K | ﹤0.01% | 2161 |
|
|
2019
Q1 | – | Sell |
-3,939
| Closed | -$91K | – | 2208 |
|
|
2018
Q4 | $91K | Sell |
3,939
-2,239
| -36% | -$51.7K | ﹤0.01% | 2151 |
|
|
2018
Q3 | $198K | Buy |
6,178
+2,496
| +68% | +$80K | ﹤0.01% | 2195 |
|
|
2018
Q2 | $104K | Buy |
+3,682
| New | +$104K | ﹤0.01% | 2290 |
|
|
2015
Q2 | – | Sell |
-2,612
| Closed | -$93K | – | 2252 |
|
|
2015
Q1 | $93K | Sell |
2,612
-17,310
| -87% | -$616K | ﹤0.01% | 2083 |
|
|
2014
Q4 | $452K | Sell |
19,922
-9,208
| -32% | -$209K | ﹤0.01% | 2015 |
|
|
2014
Q3 | $565K | Sell |
29,130
-32,870
| -53% | -$638K | ﹤0.01% | 1896 |
|
|
2014
Q2 | $2.25M | Sell |
62,000
-9,770
| -14% | -$355K | 0.01% | 1227 |
|
|
2014
Q1 | $2.79M | Buy |
71,770
+16,320
| +29% | +$633K | 0.01% | 1121 |
|
|
2013
Q4 | $1.58M | Buy |
55,450
+15,870
| +40% | +$452K | ﹤0.01% | 1489 |
|
|
2013
Q3 | $1.42M | Sell |
39,580
-1,840
| -4% | -$65.9K | 0.01% | 1465 |
|
|
2013
Q2 | $1.38M | Buy |
+41,420
| New | +$1.38M | ﹤0.01% | 1407 |
|